Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - doxepin hydrochloride - oral capsule - 10mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - doxepin hydrochloride - oral capsule - 25mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - doxepin hydrochloride - oral capsule - 50mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

rivopharm (uk) ltd - doxepin hydrochloride - oral capsule - 25mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

rivopharm (uk) ltd - doxepin hydrochloride - oral capsule - 50mg

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

viatris limited - doxepin hydrochloride 11.31mg equivalent to doxepin 10.00 mg (granulated);  ; doxepin hydrochloride 11.31mg equivalent to doxepin 10.00 mg (granulated) - capsule - 10 mg - active: doxepin hydrochloride 11.31mg equivalent to doxepin 10.00 mg (granulated)   excipient: colloidal silicon dioxide fea blue op   gelatin lactose monohydrate magnesium stearate maize starch active: doxepin hydrochloride 11.31mg equivalent to doxepin 10.00 mg (granulated) excipient: brilliant blue fcf colloidal silicon dioxide erythrosine gelatin   iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch titanium dioxide  

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

viatris limited - doxepin hydrochloride 28.27mg (granulated. = doxepin 25 mg);  ; doxepin hydrochloride 28.27mg (granulated. = doxepin 25 mg) - capsule - 25 mg - active: doxepin hydrochloride 28.27mg (granulated. = doxepin 25 mg)   excipient: colloidal silicon dioxide fed flesh op   gelatin lactose monohydrate magnesium stearate maize starch active: doxepin hydrochloride 28.27mg (granulated. = doxepin 25 mg) excipient: colloidal silicon dioxide erythrosine gelatin   iron oxide red   lactose monohydrate magnesium stearate maize starch titanium dioxide  

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

viatris limited - doxepin hydrochloride 56.54mg (granulated. = doxepin 50 mg);  ; doxepin hydrochloride 56.54mg (granulated. = doxepin 50 mg) - capsule - 50 mg - active: doxepin hydrochloride 56.54mg (granulated. = doxepin 50 mg)   excipient: colloidal silicon dioxide fea scarlet op   gelatin lactose monohydrate magnesium stearate maize starch active: doxepin hydrochloride 56.54mg (granulated. = doxepin 50 mg) excipient: colloidal silicon dioxide erythrosine gelatin   iron oxide yellow lactose monohydrate magnesium stearate maize starch sunset yellow fcf titanium dioxide   - symptoms of depressive illness, especially where sedation is required. doxepin may be used with benefit where symptoms are of short or long duration prior to treatment and in patients with a wide range of intensity of illness. as with other psychotherapeutic agents, the degree of response varies with each patient. in patients exhibiting a beneficial response, this may be seen within a few days of commencing therapy, while others may not respond for two weeks or longer. due to its excellent toleration, doxepin is particularly useful in ambulatory patients seen in general practice as well as in the treatment of hospitalised patients.